The PI3K-mTOR Pathway
暂无分享,去创建一个
[1] G. Thomas,et al. A liaison between mTOR signaling, ribosome biogenesis and cancer. , 2015, Biochimica et biophysica acta.
[2] Stan Gronthos,et al. Brief Report: The Differential Roles of mTORC1 and mTORC2 in Mesenchymal Stem Cell Differentiation , 2015, Stem cells.
[3] Suzanne F. Jones,et al. A phase 1 study of the sachet formulation of the oral dual PI3K/mTOR inhibitor BEZ235 given twice daily (BID) in patients with advanced solid tumors , 2015, Investigational new drugs.
[4] G. Shapiro,et al. First-in-Human Study of PF-05212384 (PKI-587), a Small-Molecule, Intravenous, Dual Inhibitor of PI3K and mTOR in Patients with Advanced Cancer , 2015, Clinical Cancer Research.
[5] Lei Nie,et al. FDA Approval: Idelalisib Monotherapy for the Treatment of Patients with Follicular Lymphoma and Small Lymphocytic Lymphoma , 2015, Clinical Cancer Research.
[6] A. Lane,et al. Regulation of mammalian nucleotide metabolism and biosynthesis , 2015, Nucleic acids research.
[7] Qunli Xu,et al. PI3K/mTOR dual inhibitor VS-5584 preferentially targets cancer stem cells. , 2015, Cancer research.
[8] Michael N. Hall,et al. mTORC1 mediated translational elongation limits intestinal tumour initiation and growth , 2014, Nature.
[9] Obi L. Griffith,et al. Convergent loss of PTEN leads to clinical resistance to a PI3Kα inhibitor , 2014, Nature.
[10] S. Gygi,et al. The Sestrins interact with GATOR2 to negatively regulate the amino-acid-sensing pathway upstream of mTORC1. , 2014, Cell reports.
[11] R. E. Hughes,et al. DEPTOR Is a Stemness Factor That Regulates Pluripotency of Embryonic Stem Cells* , 2014, The Journal of Biological Chemistry.
[12] D. Guertin,et al. Rictor/mTORC2 loss in the Myf5 lineage reprograms brown fat metabolism and protects mice against obesity and metabolic disease. , 2014, Cell reports.
[13] T. Wood,et al. Conditional Ablation of Raptor or Rictor Has Differential Impact on Oligodendrocyte Differentiation and CNS Myelination , 2014, The Journal of Neuroscience.
[14] Edward L Huttlin,et al. Proteomic analysis of cap-dependent translation identifies LARP1 as a key regulator of 5′TOP mRNA translation , 2014, Genes & development.
[15] L. Cantley,et al. Spatial Control of the TSC Complex Integrates Insulin and Nutrient Regulation of mTORC1 at the Lysosome , 2014, Cell.
[16] A. Merlo,et al. MNK1 pathway activity maintains protein synthesis in rapalog-treated gliomas. , 2014, The Journal of clinical investigation.
[17] P. LoRusso,et al. Phase I study of PF-04691502, a small-molecule, oral, dual inhibitor of PI3K and mTOR, in patients with advanced cancer , 2014, Investigational New Drugs.
[18] N. Sonenberg,et al. mTORC1 controls mitochondrial activity and biogenesis through 4E-BP-dependent translational regulation. , 2013, Cell metabolism.
[19] D. Sabatini,et al. The folliculin tumor suppressor is a GAP for the RagC/D GTPases that signal amino acid levels to mTORC1. , 2013, Molecular cell.
[20] Rong Li,et al. Autophagy contributes to the survival of CD133+ liver cancer stem cells in the hypoxic and nutrient-deprived tumor microenvironment. , 2013, Cancer letters.
[21] T. Herbert,et al. Evidence for Rapamycin Toxicity in Pancreatic β-Cells and a Review of the Underlying Molecular Mechanisms , 2013, Diabetes.
[22] Hideo Kusano,et al. LARP1 specifically recognizes the 3′ terminus of poly(A) mRNA , 2013, FEBS letters.
[23] J. Christensen,et al. Antitumor Efficacy of the Dual PI3K/mTOR Inhibitor PF-04691502 in a Human Xenograft Tumor Model Derived from Colorectal Cancer Stem Cells Harboring a PIK3CA Mutation , 2013, PloS one.
[24] O. Pardo,et al. S6K2: The Neglected S6 Kinase Family Member , 2013, Frontiers in Oncology.
[25] C. De Virgilio,et al. Amino Acid Deprivation Inhibits TORC1 Through a GTPase-Activating Protein Complex for the Rag Family GTPase Gtr1 , 2013, Science Signaling.
[26] Matthew Meyerson,et al. A Tumor Suppressor Complex with GAP Activity for the Rag GTPases That Signal Amino Acid Sufficiency to mTORC1 , 2013, Science.
[27] M. Piccart,et al. Emerging targeted agents in metastatic breast cancer , 2013, Nature Reviews Clinical Oncology.
[28] Mauro Piacentini,et al. mTOR inhibits autophagy by controlling ULK1 ubiquitylation, self-association and function through AMBRA1 and TRAF6 , 2013, Nature Cell Biology.
[29] U. Sauer,et al. Quantitative Phosphoproteomics Reveal mTORC1 Activates de Novo Pyrimidine Synthesis , 2013, Science.
[30] J. Asara,et al. Stimulation of de Novo Pyrimidine Synthesis by Growth Signaling Through mTOR and S6K1 , 2013, Science.
[31] G. Thomas,et al. Mechanistic Target of Rapamycin (Mtor) Is Essential for Murine Embryonic Heart Development and Growth , 2013, PloS one.
[32] G. Mills,et al. BSTA Promotes mTORC2-Mediated Phosphorylation of Akt1 to Suppress Expression of FoxC2 and Stimulate Adipocyte Differentiation , 2013, Science Signaling.
[33] O. Kirak,et al. Regulation of mTORC1 by the Rag GTPases is necessary for neonatal autophagy and survival , 2012, Nature.
[34] D. V. Von Hoff,et al. Phase I pharmacokinetic and pharmacodynamic study of the pan-PI3K/mTORC vascular targeted pro-drug SF1126 in patients with advanced solid tumours and B-cell malignancies. , 2012, European journal of cancer.
[35] J. Lehár,et al. RAD001 Enhances the Potency of BEZ235 to Inhibit mTOR Signaling and Tumor Growth , 2012, PloS one.
[36] D. Sabatini,et al. Ragulator Is a GEF for the Rag GTPases that Signal Amino Acid Levels to mTORC1 , 2012, Cell.
[37] L. C. Chen,et al. Phase I safety, pharmacokinetic, and pharmacodynamic study of the oral phosphatidylinositol-3-kinase and mTOR inhibitor BGT226 in patients with advanced solid tumors. , 2012, Annals of oncology : official journal of the European Society for Medical Oncology.
[38] I. Stansfield,et al. An MBoC Favorite: TOR controls translation initiation and early G1 progression in yeast , 2012, Molecular biology of the cell.
[39] E. White,et al. Autophagy Suppresses RIP Kinase-Dependent Necrosis Enabling Survival to mTOR Inhibition , 2012, PloS one.
[40] A. Sonntag,et al. Response to Comment on “A Dynamic Network Model of mTOR Signaling Reveals TSC-Independent mTORC2 Regulation”: Building a Model of the mTOR Signaling Network with a Potentially Faulty Tool , 2012, Science Signaling.
[41] S. Thorgeirsson,et al. mTOR Inhibitors Synergize on Regression, Reversal of Gene Expression, and Autophagy in Hepatocellular Carcinoma , 2012, Science Translational Medicine.
[42] KyeongJin Kim,et al. S6 kinase 2 deficiency enhances ketone body production and increases peroxisome proliferator‐activated receptor alpha activity in the liver , 2012, Hepatology.
[43] Yong Chen,et al. MTORC1 functions as a transcriptional regulator of autophagy by preventing nuclear transport of TFEB , 2012, Autophagy.
[44] J. Olefsky,et al. Liver-specific p70 S6 Kinase Depletion Protects against Hepatic Steatosis and Systemic Insulin Resistance* , 2012, The Journal of Biological Chemistry.
[45] D. Sabatini,et al. A unifying model for mTORC1-mediated regulation of mRNA translation , 2012, Nature.
[46] D. Sabatini,et al. mTOR Signaling in Growth Control and Disease , 2012, Cell.
[47] A. Sonntag,et al. A Dynamic Network Model of mTOR Signaling Reveals TSC-Independent mTORC2 Regulation , 2012, Science Signaling.
[48] D. Hardie,et al. AMPK: a nutrient and energy sensor that maintains energy homeostasis , 2012, Nature Reviews Molecular Cell Biology.
[49] O. Pardo,et al. Tumor Suppressor PDCD4 Represses Internal Ribosome Entry Site-Mediated Translation of Antiapoptotic Proteins and Is Regulated by S6 Kinase 2 , 2012, Molecular and Cellular Biology.
[50] G. Mills,et al. PIK3CA/PTEN Mutations and Akt Activation As Markers of Sensitivity to Allosteric mTOR Inhibitors , 2012, Clinical Cancer Research.
[51] Dudley Lamming,et al. Rapamycin-Induced Insulin Resistance Is Mediated by mTORC2 Loss and Uncoupled from Longevity , 2012, Science.
[52] Nicholas T. Ingolia,et al. The translational landscape of mTOR signalling steers cancer initiation and metastasis , 2012, Nature.
[53] P. Sorger,et al. Kinome-wide Selectivity Profiling of ATP-competitive Mammalian Target of Rapamycin (mTOR) Inhibitors and Characterization of Their Binding Kinetics* , 2012, The Journal of Biological Chemistry.
[54] Jianren Gu,et al. Transient mTOR Inhibition Facilitates Continuous Growth of Liver Tumors by Modulating the Maintenance of CD133+ Cell Populations , 2011, PloS one.
[55] M. Hall,et al. Rapamycin passes the torch: a new generation of mTOR inhibitors , 2011, Nature Reviews Drug Discovery.
[56] Roberto Zoncu,et al. mTORC1 Senses Lysosomal Amino Acids Through an Inside-Out Mechanism That Requires the Vacuolar H+-ATPase , 2011, Science.
[57] K. Shokat,et al. The mammalian target of rapamycin regulates cholesterol biosynthetic gene expression and exhibits a rapamycin-resistant transcriptional profile , 2011, Proceedings of the National Academy of Sciences.
[58] Anne E Carpenter,et al. mTOR Complex 1 Regulates Lipin 1 Localization to Control the SREBP Pathway , 2011, Cell.
[59] M. Broggini,et al. Combination of PI3K/mTOR inhibitors: antitumor activity and molecular correlates. , 2011, Cancer research.
[60] J. Albrecht,et al. S6 kinase 1 is required for rapamycin-sensitive liver proliferation after mouse hepatectomy. , 2011, The Journal of clinical investigation.
[61] F. Khuri,et al. The Combination of RAD001 and NVP-BEZ235 Exerts Synergistic Anticancer Activity against Non-Small Cell Lung Cancer In Vitro and In Vivo , 2011, PloS one.
[62] S. Gygi,et al. Phosphoproteomic Analysis Identifies Grb10 as an mTORC1 Substrate That Negatively Regulates Insulin Signaling , 2011, Science.
[63] D. Alessi,et al. Protor-1 is required for efficient mTORC2-mediated activation of SGK1 in the kidney. , 2011, The Biochemical journal.
[64] E. Goncharova,et al. mTORC2 Is Required for Proliferation and Survival of TSC2-Null Cells , 2011, Molecular and Cellular Biology.
[65] D. Sabatini,et al. The mTOR-Regulated Phosphoproteome Reveals a Mechanism of mTORC1-Mediated Inhibition of Growth Factor Signaling , 2011, Science.
[66] A. Erol. Comment on: Kumar et al. Fat Cell–Specific Ablation of Rictor in Mice Impairs Insulin-Regulated Fat Cell and Whole-Body Glucose and Lipid Metabolism. Diabetes 2010;59:1397–1406 , 2011, Diabetes.
[67] Heinrich Jasper,et al. EGF signaling regulates the proliferation of intestinal stem cells in Drosophila , 2011, Development.
[68] Xiaodong Wang,et al. Nutrient starvation elicits an acute autophagic response mediated by Ulk1 dephosphorylation and its subsequent dissociation from AMPK , 2011, Proceedings of the National Academy of Sciences.
[69] W. Oppliger,et al. Activation of mTORC2 by Association with the Ribosome , 2011, Cell.
[70] Carlos L. Arteaga,et al. Feedback upregulation of HER3 (ErbB3) expression and activity attenuates antitumor effect of PI3K inhibitors , 2011, Proceedings of the National Academy of Sciences.
[71] Weiping Yuan,et al. Rictor/mTORC2 Is Essential for Maintaining a Balance Between β-Cell Proliferation and Cell Size , 2011, Diabetes.
[72] B. Viollet,et al. AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1 , 2011, Nature Cell Biology.
[73] K. Baar,et al. Signals mediating skeletal muscle remodeling by resistance exercise: PI3-kinase independent activation of mTORC1. , 2011, Journal of applied physiology.
[74] V. Wacheck,et al. Vertical inhibition of the mTORC1/mTORC2/PI3K pathway shows synergistic effects against melanoma in vitro and in vivo. , 2011, The Journal of investigative dermatology.
[75] B. Viollet,et al. Phosphorylation of ULK1 (hATG1) by AMP-Activated Protein Kinase Connects Energy Sensing to Mitophagy , 2011, Science.
[76] A. Gould,et al. Fat cells reactivate quiescent neuroblasts via TOR and glial Insulin relays in Drosophila , 2011, Nature.
[77] D. Sabatini,et al. mTORC1 controls fasting-induced ketogenesis and its modulation by ageing , 2010, Nature.
[78] A. Brand,et al. Nutrition-Responsive Glia Control Exit of Neural Stem Cells from Quiescence , 2010, Cell.
[79] D. Sabatini,et al. mTOR: from growth signal integration to cancer, diabetes and ageing , 2010, Nature Reviews Molecular Cell Biology.
[80] K. Tachibana,et al. Dual blocking of mTor and PI3K elicits a prodifferentiation effect on glioblastoma stem-like cells. , 2010, Neuro-oncology.
[81] C. James,et al. Akt and Autophagy Cooperate to Promote Survival of Drug-Resistant Glioma , 2010, Science Signaling.
[82] Arata Tomiyama,et al. Crosstalk Between the PI3K/mTOR and MEK/ERK Pathways Involved in the Maintenance of Self‐Renewal and Tumorigenicity of Glioblastoma Stem‐Like Cells , 2010, Stem cells.
[83] J. Tabernero,et al. Targeting the PI3K/Akt/mTOR Pathway – Beyond Rapalogs , 2010, Oncotarget.
[84] P. Sun,et al. TSC1/2 tumour suppressor complex maintains Drosophila germline stem cells by preventing differentiation , 2010, Development.
[85] C. Parent,et al. Ras-mediated activation of the TORC2–PKB pathway is critical for chemotaxis , 2010, The Journal of cell biology.
[86] H. Hsu,et al. Specific roles of Target of rapamycin in the control of stem cells and their progeny in the Drosophila ovary , 2010, Development.
[87] L. Elghazi,et al. Decreased IRS Signaling Impairs β-Cell Cycle Progression and Survival in Transgenic Mice Overexpressing S6K in β-Cells , 2010, Diabetes.
[88] Qicheng Ma,et al. Activation of a metabolic gene regulatory network downstream of mTOR complex 1. , 2010, Molecular cell.
[89] G. Schatten,et al. mTOR-mediated activation of p70 S6K induces differentiation of pluripotent human embryonic stem cells. , 2010, Cellular reprogramming.
[90] A. Kimchi,et al. DAP1, a Novel Substrate of mTOR, Negatively Regulates Autophagy , 2010, Current Biology.
[91] N. Sonenberg,et al. mTORC1-Mediated Cell Proliferation, But Not Cell Growth, Controlled by the 4E-BPs , 2010, Science.
[92] N. Sonenberg,et al. S6K1 plays a critical role in early adipocyte differentiation. , 2010, Developmental cell.
[93] Pascale G. Charest,et al. A Ras signaling complex controls the RasC-TORC2 pathway and directed cell migration. , 2010, Developmental cell.
[94] B. Viollet,et al. Metformin, independent of AMPK, inhibits mTORC1 in a rag GTPase-dependent manner. , 2010, Cell metabolism.
[95] Tohru Natsume,et al. Tti1 and Tel2 Are Critical Factors in Mammalian Target of Rapamycin Complex Assembly* , 2010, The Journal of Biological Chemistry.
[96] D. Felsher,et al. MYC as a regulator of ribosome biogenesis and protein synthesis , 2010, Nature Reviews Cancer.
[97] D. Sabatini,et al. Ragulator-Rag Complex Targets mTORC1 to the Lysosomal Surface and Is Necessary for Its Activation by Amino Acids , 2010, Cell.
[98] M. Magnuson,et al. Fat Cell–Specific Ablation of Rictor in Mice Impairs Insulin-Regulated Fat Cell and Whole-Body Glucose and Lipid Metabolism , 2010, Diabetes.
[99] R. Jackson,et al. The mechanism of eukaryotic translation initiation and principles of its regulation , 2010, Nature Reviews Molecular Cell Biology.
[100] Shijie Li,et al. Bifurcation of insulin signaling pathway in rat liver: mTORC1 required for stimulation of lipogenesis, but not inhibition of gluconeogenesis , 2010, Proceedings of the National Academy of Sciences.
[101] D. Sabatini,et al. An Emerging Role of mTOR in Lipid Biosynthesis , 2009, Current Biology.
[102] N. Saijo,et al. mTOR signal and hypoxia-inducible factor-1 alpha regulate CD133 expression in cancer cells. , 2009, Cancer research.
[103] L. Chodosh,et al. mTOR mediates Wnt-induced epidermal stem cell exhaustion and aging. , 2009, Cell stem cell.
[104] J. Asara,et al. Characterization of Rictor Phosphorylation Sites Reveals Direct Regulation of mTOR Complex 2 by S6K1 , 2009, Molecular and Cellular Biology.
[105] Chin-Lee Wu,et al. Insulin Stimulates Adipogenesis through the Akt-TSC2-mTORC1 Pathway , 2009, PloS one.
[106] Yiling Lu,et al. AKT-independent signaling downstream of oncogenic PIK3CA mutations in human cancer. , 2009, Cancer cell.
[107] J. Auwerx,et al. mTOR complex 2 in adipose tissue negatively controls whole-body growth , 2009, Proceedings of the National Academy of Sciences.
[108] D. Sabatini,et al. DEPTOR Is an mTOR Inhibitor Frequently Overexpressed in Multiple Myeloma Cells and Required for Their Survival , 2009, Cell.
[109] L. Gesualdo,et al. Management of Side Effects of Sirolimus Therapy , 2009, Transplantation.
[110] D. Sabatini,et al. mTOR and cancer: many loops in one pathway. , 2009, Current opinion in cell biology.
[111] D. Sabatini,et al. An ATP-competitive Mammalian Target of Rapamycin Inhibitor Reveals Rapamycin-resistant Functions of mTORC1* , 2009, Journal of Biological Chemistry.
[112] A. Hinnebusch,et al. Regulation of Translation Initiation in Eukaryotes: Mechanisms and Biological Targets , 2009, Cell.
[113] B. Manning,et al. A complex interplay between Akt, TSC2 and the two mTOR complexes. , 2009, Biochemical Society transactions.
[114] Robbie Loewith,et al. Active-Site Inhibitors of mTOR Target Rapamycin-Resistant Outputs of mTORC1 and mTORC2 , 2009, PLoS biology.
[115] Dexin Kong,et al. Effect of ZSTK474, a novel phosphatidylinositol 3-kinase inhibitor, on DNA-dependent protein kinase. , 2009, Biological & pharmaceutical bulletin.
[116] Y. Ip,et al. Tissue damage-induced intestinal stem cell division in Drosophila. , 2009, Cell stem cell.
[117] P. Schultz,et al. The role of PTEN/Akt/PI3K signaling in the maintenance and viability of prostate cancer stem-like cell populations , 2009, Proceedings of the National Academy of Sciences.
[118] D. Alessi,et al. mTOR complex 2 (mTORC2) controls hydrophobic motif phosphorylation and activation of serum- and glucocorticoid-induced protein kinase 1 (SGK1). , 2008, The Biochemical journal.
[119] Hiraku Ono,et al. Mediobasal hypothalamic p70 S6 kinase 1 modulates the control of energy homeostasis. , 2008, Cell metabolism.
[120] Sang Gyun Kim,et al. Rapamycin differentially inhibits S6Ks and 4E-BP1 to mediate cell-type-specific repression of mRNA translation , 2008, Proceedings of the National Academy of Sciences.
[121] J. Auwerx,et al. Adipose-specific knockout of raptor results in lean mice with enhanced mitochondrial respiration. , 2008, Cell metabolism.
[122] E. Casanova,et al. Skeletal muscle-specific ablation of raptor, but not of rictor, causes metabolic changes and results in muscle dystrophy. , 2008, Cell metabolism.
[123] T. Fujimura,et al. The Atg8 conjugation system is indispensable for proper development of autophagic isolation membranes in mice. , 2008, Molecular biology of the cell.
[124] Claudio R. Santos,et al. SREBP Activity Is Regulated by mTORC1 and Contributes to Akt-Dependent Cell Growth , 2008, Cell metabolism.
[125] P. Pandolfi,et al. Inhibition of mTORC1 leads to MAPK pathway activation through a PI3K-dependent feedback loop in human cancer. , 2008, The Journal of clinical investigation.
[126] M. Karin,et al. p53 Target Genes Sestrin1 and Sestrin2 Connect Genotoxic Stress and mTOR Signaling , 2008, Cell.
[127] K. Inoki,et al. Essential function of TORC2 in PKC and Akt turn motif phosphorylation, maturation and signalling , 2008, The EMBO journal.
[128] P. Iglesias,et al. PIP3-Independent Activation of TorC2 and PKB at the Cell's Leading Edge Mediates Chemotaxis , 2008, Current Biology.
[129] S. Woods,et al. The Role of Hypothalamic Mammalian Target of Rapamycin Complex 1 Signaling in Diet-Induced Obesity , 2008, The Journal of Neuroscience.
[130] M. Gambello,et al. Disruption of Tsc2 in pancreatic β cells induces β cell mass expansion and improved glucose tolerance in a TORC1-dependent manner , 2008, Proceedings of the National Academy of Sciences.
[131] T. P. Neufeld,et al. Regulation of TORC1 by Rag GTPases in nutrient response , 2008, Nature Cell Biology.
[132] Daniela Gabriel,et al. Identification and characterization of NVP-BEZ235, a new orally available dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor with potent in vivo antitumor activity , 2008, Molecular Cancer Therapeutics.
[133] David M. Sabatini,et al. The Rag GTPases Bind Raptor and Mediate Amino Acid Signaling to mTORC1 , 2008, Science.
[134] B. Manning,et al. The TSC1-TSC2 complex: a molecular switchboard controlling cell growth. , 2008, The Biochemical journal.
[135] Lil Pabon,et al. A hierarchical network controls protein translation during murine embryonic stem cell self-renewal and differentiation. , 2008, Cell stem cell.
[136] W. Birchmeier,et al. Wnt signalling and its impact on development and cancer , 2008, Nature Reviews Cancer.
[137] B. Turk,et al. AMPK phosphorylation of raptor mediates a metabolic checkpoint. , 2008, Molecular cell.
[138] B. Manning,et al. The TSC1-TSC2 Complex Is Required for Proper Activation of mTOR Complex 2 , 2008, Molecular and Cellular Biology.
[139] Y. Kido,et al. Biphasic Response of Pancreatic β-Cell Mass to Ablation of Tuberous Sclerosis Complex 2 in Mice , 2008, Molecular and Cellular Biology.
[140] J. Goldstein,et al. Selective versus total insulin resistance: a pathogenic paradox. , 2008, Cell metabolism.
[141] D. Sgroi,et al. Hypoxia regulates TSC1/2-mTOR signaling and tumor suppression through REDD1-mediated 14-3-3 shuttling. , 2008, Genes & development.
[142] S. Horvath,et al. Antitumor Activity of Rapamycin in a Phase I Trial for Patients with Recurrent PTEN-Deficient Glioblastoma , 2008, PLoS medicine.
[143] J. Downward,et al. Functional inhibition of PI3K by the βGBP molecule suppresses Ras–MAPK signalling to block cell proliferation , 2007, Oncogene.
[144] V. Mootha,et al. mTOR controls mitochondrial oxidative function through a YY1–PGC-1α transcriptional complex , 2007, Nature.
[145] Adiel Cohen,et al. PRAS40 and PRR5-Like Protein Are New mTOR Interactors that Regulate Apoptosis , 2007, PloS one.
[146] J. Margolick,et al. Activation of the PTEN/mTOR/STAT3 pathway in breast cancer stem-like cells is required for viability and maintenance , 2007, Proceedings of the National Academy of Sciences.
[147] J. Menéndez,et al. Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis , 2007, Nature Reviews Cancer.
[148] Yu Li,et al. Identification of IRS-1 Ser-1101 as a target of S6K1 in nutrient- and obesity-induced insulin resistance , 2007, Proceedings of the National Academy of Sciences.
[149] G. Hortobagyi,et al. IKKβ Suppression of TSC1 Links Inflammation and Tumor Angiogenesis via the mTOR Pathway , 2007, Cell.
[150] D. Alessi,et al. Identification of Protor as a novel Rictor-binding component of mTOR complex-2. , 2007, The Biochemical journal.
[151] R. Roth,et al. PRAS40 Regulates mTORC1 Kinase Activity by Functioning as a Direct Inhibitor of Substrate Binding* , 2007, Journal of Biological Chemistry.
[152] G. Thomas,et al. mTOR Complex1-S6K1 signaling: at the crossroads of obesity, diabetes and cancer. , 2007, Trends in molecular medicine.
[153] G. Stamp,et al. Binding of Ras to Phosphoinositide 3-Kinase p110α Is Required for Ras- Driven Tumorigenesis in Mice , 2007, Cell.
[154] R. Lehmann,et al. Germ Versus Soma Decisions: Lessons from Flies and Worms , 2007, Science.
[155] S. Carr,et al. PRAS40 is an insulin-regulated inhibitor of the mTORC1 protein kinase. , 2007, Molecular cell.
[156] Annie P. Moseman,et al. PDGFRs are critical for PI3K/Akt activation and negatively regulated by mTOR. , 2007, The Journal of clinical investigation.
[157] Timothy J. Griffin,et al. Insulin signalling to mTOR mediated by the Akt/PKB substrate PRAS40 , 2007, Nature Cell Biology.
[158] N. Sonenberg,et al. Elevated sensitivity to diet-induced obesity and insulin resistance in mice lacking 4E-BP1 and 4E-BP2. , 2007, The Journal of clinical investigation.
[159] D. Guertin,et al. Ablation in mice of the mTORC components raptor, rictor, or mLST8 reveals that mTORC2 is required for signaling to Akt-FOXO and PKCalpha, but not S6K1. , 2006, Developmental cell.
[160] Michele Pagano,et al. S6K1- and ßTRCP-Mediated Degradation of PDCD4 Promotes Protein Translation and Cell Growth , 2006, Science.
[161] J. Qin,et al. SIN1/MIP1 Maintains rictor-mTOR Complex Integrity and Regulates Akt Phosphorylation and Substrate Specificity , 2006, Cell.
[162] Q. She,et al. AKT and cancer--is it all mTOR? , 2006, Cancer cell.
[163] J. Woo,et al. Multiallelic disruption of the rictor gene in mice reveals that mTOR complex 2 is essential for fetal growth and viability. , 2006, Developmental cell.
[164] Jacob D. Jaffe,et al. mSin1 Is Necessary for Akt/PKB Phosphorylation, and Its Isoforms Define Three Distinct mTORC2s , 2006, Current Biology.
[165] Ming You,et al. TSC2 Integrates Wnt and Energy Signals via a Coordinated Phosphorylation by AMPK and GSK3 to Regulate Cell Growth , 2006, Cell.
[166] B. Viollet,et al. 5′-AMP-Activated Protein Kinase (AMPK) Is Induced by Low-Oxygen and Glucose Deprivation Conditions Found in Solid-Tumor Microenvironments , 2006, Molecular and Cellular Biology.
[167] G. Thomas,et al. Nutrient overload, insulin resistance, and ribosomal protein S6 kinase 1, S6K1. , 2006, Cell metabolism.
[168] George Thomas,et al. Hypothalamic mTOR Signaling Regulates Food Intake , 2006, Science.
[169] K. Inoki,et al. TSC1/TSC2 and Rheb have different effects on TORC1 and TORC2 activity. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[170] D. Sabatini,et al. Prolonged rapamycin treatment inhibits mTORC2 assembly and Akt/PKB. , 2006, Molecular cell.
[171] Gordon B Mills,et al. mTOR inhibition induces upstream receptor tyrosine kinase signaling and activates Akt. , 2006, Cancer research.
[172] F. Natt,et al. Amino acids mediate mTOR/raptor signaling through activation of class 3 phosphatidylinositol 3OH-kinase. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[173] James T. Murray,et al. hVps34 Is a Nutrient-regulated Lipid Kinase Required for Activation of p70 S6 Kinase* , 2005, Journal of Biological Chemistry.
[174] A. Levine,et al. The coordinate regulation of the p53 and mTOR pathways in cells. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[175] Masaaki Komatsu,et al. Impairment of starvation-induced and constitutive autophagy in Atg7-deficient mice , 2005, The Journal of cell biology.
[176] Joseph Avruch,et al. Rheb Binds and Regulates the mTOR Kinase , 2005, Current Biology.
[177] Paul Tempst,et al. Phosphorylation and Functional Inactivation of TSC2 by Erk Implications for Tuberous Sclerosisand Cancer Pathogenesis , 2005, Cell.
[178] H. Lane,et al. The mTOR Inhibitor RAD001 Sensitizes Tumor Cells to DNA-Damaged Induced Apoptosis through Inhibition of p21 Translation , 2005, Cell.
[179] A. Marette,et al. Increased activation of the mammalian target of rapamycin pathway in liver and skeletal muscle of obese rats: possible involvement in obesity-linked insulin resistance. , 2005, Endocrinology.
[180] Takeshi Tokuhisa,et al. The role of autophagy during the early neonatal starvation period , 2004, Nature.
[181] E. Hafen,et al. The hypoxia-induced paralogs Scylla and Charybdis inhibit growth by down-regulating S6K activity upstream of TSC in Drosophila. , 2004, Genes & development.
[182] E. Hafen,et al. Regulation of mTOR function in response to hypoxia by REDD1 and the TSC1/TSC2 tumor suppressor complex. , 2004, Genes & development.
[183] R. Loewith,et al. Mammalian TOR complex 2 controls the actin cytoskeleton and is rapamycin insensitive , 2004, Nature Cell Biology.
[184] G. Thomas,et al. Disruption of the Mouse mTOR Gene Leads to Early Postimplantation Lethality and Prohibits Embryonic Stem Cell Development , 2004, Molecular and Cellular Biology.
[185] Jie Chen,et al. regulation of peroxisome proliferator-activated receptor-gamma activity by mammalian target of rapamycin and amino acids in adipogenesis. , 2004, Diabetes.
[186] Johan Auwerx,et al. Absence of S6K1 protects against age- and diet-induced obesity while enhancing insulin sensitivity , 2004, Nature.
[187] N. Sonenberg,et al. Upstream and downstream of mTOR. , 2004, Genes & development.
[188] M. Murakami,et al. mTOR Is Essential for Growth and Proliferation in Early Mouse Embryos and Embryonic Stem Cells , 2004, Molecular and Cellular Biology.
[189] R. Lehmann,et al. Germ Cell Specification and Migration in Drosophila and beyond , 2004, Current Biology.
[190] D. Guertin,et al. Rictor, a Novel Binding Partner of mTOR, Defines a Rapamycin-Insensitive and Raptor-Independent Pathway that Regulates the Cytoskeleton , 2004, Current Biology.
[191] I. Gout,et al. The TSC1-2 tumor suppressor controls insulin–PI3K signaling via regulation of IRS proteins , 2004, The Journal of cell biology.
[192] R. DePinho,et al. The LKB1 tumor suppressor negatively regulates mTOR signaling. , 2004, Cancer cell.
[193] P. Pandolfi,et al. The translation factor eIF-4E promotes tumor formation and cooperates with c-Myc in lymphomagenesis , 2004, Nature Medicine.
[194] I. Grummt,et al. mTOR-dependent activation of the transcription factor TIF-IA links rRNA synthesis to nutrient availability. , 2004, Genes & development.
[195] K. Inoki,et al. TSC2 Mediates Cellular Energy Response to Control Cell Growth and Survival , 2003, Cell.
[196] William R Sellers,et al. TSC2 regulates VEGF through mTOR-dependent and -independent pathways. , 2003, Cancer cell.
[197] Yoshinori Watanabe,et al. Schizosaccharomyces pombe AGC family kinase Gad8p forms a conserved signaling module with TOR and PDK1‐like kinases , 2003, The EMBO journal.
[198] E. Hafen,et al. Insulin activation of Rheb, a mediator of mTOR/S6K/4E-BP signaling, is inhibited by TSC1 and 2. , 2003, Molecular cell.
[199] Paul Tempst,et al. GbetaL, a positive regulator of the rapamycin-sensitive pathway required for the nutrient-sensitive interaction between raptor and mTOR. , 2003, Molecular cell.
[200] A. Hodges,et al. Tuberous sclerosis complex tumor suppressor–mediated S6 kinase inhibition by phosphatidylinositide-3-OH kinase is mTOR independent , 2002, The Journal of cell biology.
[201] G. Thomas,et al. Lethality of Drosophila lacking TSC tumor suppressor function rescued by reducing dS6K signaling. , 2002, Genes & development.
[202] Christine C. Hudson,et al. Regulation of Hypoxia-Inducible Factor 1α Expression and Function by the Mammalian Target of Rapamycin , 2002, Molecular and Cellular Biology.
[203] J. Avruch,et al. TOR Deficiency in C. elegans Causes Developmental Arrest and Intestinal Atrophy by Inhibition of mRNA Translation , 2002, Current Biology.
[204] J. Crespo,et al. Two TOR complexes, only one of which is rapamycin sensitive, have distinct roles in cell growth control. , 2002, Molecular cell.
[205] J. Avruch,et al. Raptor, a Binding Partner of Target of Rapamycin (TOR), Mediates TOR Action , 2002, Cell.
[206] J. Blenis,et al. Identification of a Conserved Motif Required for mTOR Signaling , 2002, Current Biology.
[207] E. Hafen,et al. dS6K-regulated cell growth is dPKB/dPI(3)K-independent, but requires dPDK1 , 2002, Nature cell biology.
[208] S K Burley,et al. Hierarchical phosphorylation of the translation inhibitor 4E-BP1. , 2001, Genes & development.
[209] C. Proud,et al. Regulation of elongation factor 2 kinase by p90RSK1 and p70 S6 kinase , 2001, The EMBO journal.
[210] T. Haruta,et al. Mammalian Target of Rapamycin Pathway Regulates Insulin Signaling via Subcellular Redistribution of Insulin Receptor Substrate 1 and Integrates Nutritional Signals and Metabolic Signals of Insulin , 2001, Molecular and Cellular Biology.
[211] G. Semenza,et al. HER2 (neu) Signaling Increases the Rate of Hypoxia-Inducible Factor 1α (HIF-1α) Synthesis: Novel Mechanism for HIF-1-Mediated Vascular Endothelial Growth Factor Expression , 2001, Molecular and Cellular Biology.
[212] R. Burcelin,et al. Hypoinsulinaemia, glucose intolerance and diminished β-cell size in S6K1-deficient mice , 2000, Nature.
[213] T. P. Neufeld,et al. Regulation of cellular growth by the Drosophila target of rapamycin dTOR. , 2000, Genes & development.
[214] E. Hafen,et al. Genetic and biochemical characterization of dTOR, the Drosophila homolog of the target of rapamycin. , 2000, Genes & development.
[215] J. Olefsky,et al. A rapamycin-sensitive pathway down-regulates insulin signaling via phosphorylation and proteasomal degradation of insulin receptor substrate-1. , 2000, Molecular endocrinology.
[216] E. Hafen,et al. Drosophila S6 kinase: a regulator of cell size. , 1999, Science.
[217] J. Downward,et al. Role of Phosphoinositide 3-Kinase in Activation of Ras and Mitogen-Activated Protein Kinase by Epidermal Growth Factor , 1999, Molecular and Cellular Biology.
[218] S. Gygi,et al. Regulation of 4E-BP1 phosphorylation: a novel two-step mechanism. , 1999, Genes & development.
[219] S. Gygi,et al. Protein analysis by mass spectrometry and sequence database searching: Tools for cancer research in the post‐genomic era , 1999, Electrophoresis.
[220] A. Gingras,et al. Human eukaryotic translation initiation factor 4G (eIF4G) recruits Mnk1 to phosphorylate eIF4E , 1999, The EMBO journal.
[221] G. Brown,et al. Cellular energy utilization and molecular origin of standard metabolic rate in mammals. , 1997, Physiological reviews.
[222] R. Pearson,et al. Rapamycin suppresses 5′TOP mRNA translation through inhibition of p70s6k , 1997, The EMBO journal.
[223] F. Buttgereit,et al. A hierarchy of ATP-consuming processes in mammalian cells. , 1995, The Biochemical journal.
[224] Stuart L. Schreiber,et al. TOR kinase domains are required for two distinct functions, only one of which is inhibited by rapamycin , 1995, Cell.
[225] G. Thomas,et al. Rapamycin selectively represses translation of the "polypyrimidine tract" mRNA family. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[226] S. Schreiber,et al. FKBP-rapamycin inhibits a cyclin-dependent kinase activity and a cyclin D1-Cdk association in early G1 of an osteosarcoma cell line. , 1993, The Journal of biological chemistry.
[227] R. Perry,et al. Oligopyrimidine tract at the 5' end of mammalian ribosomal protein mRNAs is required for their translational control. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[228] James S. Duncan,et al. Chemoproteomic characterization of protein kinase inhibitors using immobilized ATP. , 2012, Methods in molecular biology.
[229] Michael B. Mathews,et al. Translational control in biology and medicine , 2007 .
[230] Geoffrey M Cooper,et al. Role of mTOR in the degradation of IRS‐1: Regulation of PP2A activity , 2002, Journal of cellular biochemistry.
[231] C. Hagedorn,et al. Protein kinase C phosphorylates both serine and threonine residues of the mRNA cap binding protein eIF-4E. , 1992, Second messengers and phosphoproteins.